# Task C24: Process Optimization and Scale Up of an Antibiotic-Resistant Bacterial Agent

> **NIH NIH N01** · ALBANY MOLECULAR RESEARCH, INC. · 2024 · $1,905,868

## Abstract

The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.

## Key facts

- **NIH application ID:** 11178795
- **Project number:** 272201800008I-0-759302400001-1
- **Recipient organization:** ALBANY MOLECULAR RESEARCH, INC.
- **Principal Investigator:** HEIDI SCHLAGER
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $1,905,868
- **Award type:** —
- **Project period:** 2024-07-19 → 2026-01-18

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11178795

## Citation

> US National Institutes of Health, RePORTER application 11178795, Task C24: Process Optimization and Scale Up of an Antibiotic-Resistant Bacterial Agent (272201800008I-0-759302400001-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/11178795. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*